MedTrace Logo

Diagnostic Accuracy of a Panel of Bacterial Gene Markers (M3) for Colorectal Advanced Neoplasia

NCT05405673 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2024-08-27

No results posted yet for this study

Summary

The investigators aim to evaluate and compare the diagnostic accuracy of FIT and the novel panel of bacterial gene markers (Fn, m3, Ch and Bc) collectively named as M3, in detecting colorectal advanced neoplasia.

Conditions

Interventions

DIAGNOSTIC_TEST

Fecal immunochemical test (FIT)

A kind of stool test

Sponsors & Collaborators

  • Dr Cipto Mangunkusumo General Hospital

    collaborator OTHER

  • Aster CMI Hospital

    collaborator UNKNOWN

  • Osaka International Cancer Institute

    collaborator UNKNOWN

  • Sano hospital

    collaborator UNKNOWN

  • Thingangyun Sanpya General Hospital

    collaborator UNKNOWN

  • Changi General Hospital

    collaborator OTHER

  • National Taiwan University Hospital

    collaborator OTHER

  • Phramongkutklao College of Medicine and Hospital

    collaborator OTHER

  • St. Mark's Hospital

    collaborator UNKNOWN

  • Oxford University Hospitals NHS Trust

    collaborator OTHER

  • Chinese University of Hong Kong

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-29
Primary Completion
2025-06-15
Completion
2025-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05405673 on ClinicalTrials.gov